Top

Published in:

01-08-2016 | Original Paper

Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery

Authors: Andrew Xingyu Zhou, Wyatt Boyer Messenger, Steven Sargent, Balamurali Krishna Ambati

Published in: International Ophthalmology | Issue 4/2016

Abstract

The objective of this study is to evaluate the safety of undiluted 0.5 % intracameral moxifloxacin for postoperative endophthalmitis prophylaxis in cataract surgery patients without the use of additional postoperative topical antibiotics. All phacoemulsification cataract surgeries performed by a single surgeon (B.A.) at the John A. Moran Eye Center from June 2012 to May 2015 were reviewed retrospectively. From June 2012 to April 2014, patients were given topical 0.5 % moxifloxacin postoperatively. From May 2014 to May 2015, all patients were given moxifloxacin intracamerally with no antibiotics postoperatively. The follow-up period was 1 month after surgery. Preoperative visual acuity and postoperative visual acuity, corneal edema, and anterior chamber reaction were recorded and compared between the two groups. 384 cataract surgeries were performed during the study period. None of the 384 eyes in the study developed endophthalmitis. Of those 384 eyes, 222 were included in the study for analysis based on the inclusion and exclusion criteria. 131 were part of the topical antibiotic group and 91 were part of the intracameral group. The differences in uncorrected visual acuity at 1 day postoperatively (p = 0.595) and best corrected visual acuity at 1 month postoperatively (p = 0.099) were not statistically significant. Differences in corneal edema (p = 0.370) and anterior chamber reaction (p = 0.069) at 1 day postoperatively and corneal edema (p = 0.512) and anterior chamber reaction (p = 0.512) at 1 month postoperatively were also not statistically significant. Undiluted 0.5 % moxifloxacin can be safely injected intracamerally following cataract surgery without additional postoperative antibiotic prophylaxis to prevent endophthalmitis without adverse effects on patient outcomes.

Cullen K, Hall M, Golosinskiy A (2009) Ambulatory surgery in the United States, 2006. National health statistics reports

Gore DM, Angunawela RI, Little BC (2009) United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study. J Cataract Refract Surg 35(4):770–773. doi:10.1016/j.jcrs.2009.01.004 CrossRefPubMed

Kam JK, Buck D, Dawkins R, Sandhu SS, Allen PJ (2014) Survey of prophylactic intracameral antibiotic use in cataract surgery in an Australian context. Clin Exp Ophthalmol 42(4):398–400. doi:10.1111/ceo.12199 CrossRef

Barry P (2014) Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study. J Cataract Refract Surg 40(1):138–142. doi:10.1016/j.jcrs.2013.11.002 CrossRefPubMed

Chang DF, Braga-Mele R, Henderson BA, Mamalis N, Vasavada A, Committee ACC (2015) Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg 41(6):1300–1305. doi:10.1016/j.jcrs.2015.01.014 CrossRefPubMed

Endophthalmitis Study Group ESoC, Refractive S (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33(6):978–988. doi:10.1016/j.jcrs.2007.02.032 CrossRef

Delyfer MN, Rougier MB, Leoni S, Zhang Q, Dalbon F, Colin J, Korobelnik JF (2011) Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg 37(2):271–278. doi:10.1016/j.jcrs.2010.08.047 CrossRefPubMed

Seppala H, Al-Juhaish M, Jarvinen H, Laitinen R, Huovinen P (2004) Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients. J Cataract Refract Surg 30(2):307–315. doi:10.1016/S0886-3350(03)00617-5 CrossRefPubMed

Stroman DW, Dajcs JJ, Cupp GA, Schlech BA (2005) In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Surv Ophthalmol 50(Suppl 1):S16–S31. doi:10.1016/j.survophthal.2005.06.002 CrossRefPubMed

10.

Espiritu CR, Caparas VL, Bolinao JG (2007) Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg 33(1):63–68. doi:10.1016/j.jcrs.2006.09.019 CrossRefPubMed

11.

Matsuura K, Miyoshi T, Suto C, Akura J, Inoue Y (2013) Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan. J Cataract Refract Surg 39(11):1702–1706. doi:10.1016/j.jcrs.2013.05.036 CrossRefPubMed

12.

Ekinci Koktekir B, Aslan BS (2012) Safety of prophylactic intracameral moxifloxacin use in cataract surgery. J Ocul Pharmacol Ther 28(3):278–282. doi:10.1089/jop.2011.0132 CrossRefPubMed

13.

Lane SS, Osher RH, Masket S, Belani S (2008) Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg 34(9):1451–1459. doi:10.1016/j.jcrs.2008.05.034 CrossRefPubMed

14.

Arbisser LB (2008) Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. J Cataract Refract Surg 34(7):1114–1120. doi:10.1016/j.jcrs.2008.03.017 CrossRefPubMed

15.

Holladay JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13(4):388–391PubMed

16.

Chen X, Adelman RA (2012) Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988-2008) review in northeast United States. J Ocul Pharmacol Ther 28(4):329–334. doi:10.1089/jop.2011.0204 CrossRefPubMed

17.

Matsuura K, Suto C, Akura J, Inoue Y (2013) Comparison between intracameral moxifloxacin administration methods by assessing intraocular concentrations and drug kinetics. Graefes Arch Clin Exp Ophthalmol 251(8):1955–1959. doi:10.1007/s00417-013-2294-7 CrossRefPubMed

18.

Sharma T, Kamath MM, Kamath MG, Nayak RR, Bairy KL, Musmade PB (2015) Aqueous penetration of orally and topically administered moxifloxacin. Br J Ophthalmol. doi:10.1136/bjophthalmol-2014-306502

19.

Robertson SM, Curtis MA, Schlech BA, Rusinko A, Owen GR, Dembinska O, Liao J, Dahlin DC (2005) Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. Surv Ophthalmol 50(Suppl 1):S32–S45. doi:10.1016/j.survophthal.2005.07.001 CrossRefPubMed

20.

Haas W, Pillar CM, Torres M, Morris TW, Sahm DF (2011) Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study. Am J Ophthalmol 152(4):567–574 e563. doi:10.1016/j.ajo.2011.03.010

21.

Holland EJ, McDonald MB, Parekh JG, Sheppard JD (2014) Antibiotic resistance in acute postoperative endophthalmitis. Ophthalmology 121(11 Suppl):S1–S9 quiz S10–S12. doi:10.1016/j.ophtha.2014.06.049

22.

O’Brien TP, Arshinoff SA, Mah FS (2007) Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg 33(10):1790–1800. doi:10.1016/j.jcrs.2007.06.026 CrossRefPubMed

23.

Olofsson SK, Cars O (2007) Optimizing drug exposure to minimize selection of antibiotic resistance. Clin Infect Dis 45(Suppl 2):S129–S136. doi:10.1086/519256 CrossRefPubMed

24.

Sharifi E, Porco TC, Naseri A (2009) Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology 116(10):1887–1896 e1881. doi:10.1016/j.ophtha.2009.03.014

25.

Nguyen ET, Shorstein NH (2013) Preparation of intracameral antibiotics for injection. J Cataract Refract Surg 39(11):1778–1779. doi:10.1016/j.jcrs.2013.08.036 CrossRefPubMed

26.

Lexicomp Online^®, Lexi-Drugs^®. Hudson, OH, USA: Lexi-Comp, Inc. Accessed 30 July 2015

27.

An JA, Kasner O, Samek DA, Levesque V (2014) Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg 40(11):1857–1861. doi:10.1016/j.jcrs.2014.02.037 CrossRefPubMed

28.

Galvis V, Tello A, Sanchez MA, Camacho PA (2014) Cohort study of intracameral moxifloxacin in postoperative endophthalmitis prophylaxis. Ophthalmol Eye Dis 6:1–4. doi:10.4137/OED.S13102 PubMedPubMedCentral

29.

Rudnisky CJ, Wan D, Weis E (2014) Antibiotic choice for the prophylaxis of post-cataract extraction endophthalmitis. Ophthalmology 121(4):835–841. doi:10.1016/j.ophtha.2013.08.046 CrossRefPubMed

30.

Shorstein NH, Winthrop KL, Herrinton LJ (2013) Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg 39(1):8–14. doi:10.1016/j.jcrs.2012.07.031 CrossRefPubMed

31.

Arshinoff SA, Bastianelli PA (2011) Incidence of postoperative endophthalmitis after immediate sequential bilateral cataract surgery. J Cataract Refract Surg 37(12):2105–2114. doi:10.1016/j.jcrs.2011.06.036 CrossRefPubMed

32.

Friling E, Lundstrom M, Stenevi U, Montan P (2013) Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg 39(1):15–21. doi:10.1016/j.jcrs.2012.10.037 CrossRefPubMed

Title: Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery
Authors: Andrew Xingyu Zhou
Wyatt Boyer Messenger
Steven Sargent
Balamurali Krishna Ambati
Publication date: 01-08-2016
Publisher: Springer Netherlands
Published in: International Ophthalmology / Issue 4/2016
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-015-0151-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2016

Clinical outcomes of trabeculectomy vs. Ahmed glaucoma valve implantation in patients with penetrating keratoplasty

Anterior segment parameters and eyelids in systemic sclerosis

Corneal endothelial cell analysis using two non-contact specular microscopes in healthy subjects

A safe method of ciliary sulcus fixation of foldable intraocular lens using a ciliary sulcus guide

The macular findings on spectral-domain optical coherence tomography in premature infants with or without retinopathy of prematurity

Predictability of horizontal versus vertical muscle surgery outcomes in thyroid eye disease